Based on transcriptional mechanisms of the midbrain dopamine neuronal system, Dr. Kim's lab focuses on developing novel mechanism - based and neuroprotective therapeutics for PD and other neurodegenerative and neuropsychiatric disorders. (mcleanhospital.org)
«Because transcription factors have proven so difficult to block with targeted therapies, we wanted to see if an alternative approach that targets these defective transcriptional mechanisms would be effective.» (sciencedaily.com)